Xylocaine Injection, Solution
Product Images NDC 51662-1645

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Xylocaine (NDC 51662-1645). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Table 1 (51662 1645 Class Examples)

Table 1 (51662 1645 Class Examples)
A data table displaying drug classes alongside examples of drugs in each class. Categories include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs, with examples such as lidocaine under Local anesthetics and phenobarbital under Anticonvulsants.*
FDA Label Image

Structure (51662 1645 Structure 2)

Structure (51662 1645 Structure 2)
Chemical structure of the active ingredient in XYLOCAINE injection solution 10 mg/mL. The diagram shows the molecular arrangement including hydroxyl groups attached to a benzene ring and an aminoethyl side chain, representing the chemical composition relevant to the pharmaceutical product.*
FDA Label Image

Structure (51662 1645 Structure)

Structure (51662 1645 Structure)
Chemical structure diagram of the active ingredient in XYLOCAINE 10 mg/mL injection solution, showing its molecular components and hydrochloride salt (HCl).*
FDA Label Image

Table 1 (51662 1645 Table 1)

Table 1 (51662 1645 Table 1)
A data table titled 'Recommended Dosages' for Xylocaine (lidocaine hydrochloride) Injection without epinephrine. It lists procedures including infiltration, peripheral nerve blocks, paracervical, sympathetic nerve blocks, central neural blocks, and caudal, detailing concentration percentages, volumes in milliliters, and total doses in milligrams for each procedure variant.*
FDA Label Image

Pouch Label (51662 1645 2 Pouch Label)

Pouch Label (51662 1645 2 Pouch Label)
XYLOCAINE (Lidocaine HCl Injection) 1% 20 mg/mL solution in a 20 mL vial. The label states the product is for infiltration and nerve block, not for caudal or epidural use. It includes active ingredient details, warnings about preservatives, and storage conditions. Manufactured by HF Acquisition Co LLC, DBA HealthFirst.*
FDA Label Image

Case Label (51662 1645 3 Case Label)

Case Label (51662 1645 3 Case Label)
Label for XYLOCAINE (Lidocaine HCl Injection) 10 mg/mL in a 20 mL vial. The label indicates the product is a human prescription drug for infiltration and perineural use, supplied in a case of 25 vials. Manufactured by HF Acquisition Co LLC, DBA HealthFirst, with NDC 51662-1645-3. The label includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.